Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis

Clinical trial NCT03274375 · COMPLETED

Trial details

NCT number: NCT03274375
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anti-NMDAR Encephalitis

Start date: 2021-06-23
Primary completion: 2023-10-26
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.